The high expression of CHST12 indicated a lower overall survival rate, was negatively associated with the Karnofsky Performance Scale (KPS) score, was positively associated with the KI67 expression rate, and was an independent risk factor for GBM. The gene discussed is CHST12; the disease is glioblastoma.